NCT01529385

Brief Summary

The purpose of this study is to determine whether a specially designed sock for people with diabetes and swelling in the legs can reduce the swelling, improve blood flow to the legs, and improve physical activity patterns of those individuals by providing mild compression to their legs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

February 3, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 8, 2012

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

June 22, 2016

Completed
Last Updated

June 22, 2016

Status Verified

May 1, 2016

Enrollment Period

2.6 years

First QC Date

February 3, 2012

Results QC Date

April 7, 2016

Last Update Submit

May 13, 2016

Conditions

Keywords

swollen legdiabetescompression stockingsedema

Outcome Measures

Primary Outcomes (9)

  • Cutaneous Water Content

    Cutaneous water content was measured non-invasively by tissue dielectric constant (MoistureMeter) at a single location: 2 inches distal and 2 inches lateral to the fibular head.

    change from baseline after 4 weeks of sock usage

  • Calf Edema

    The circumference of calf was measured by a tape measure.

    change from baseline after 4 weeks of sock usage

  • Ankle Edema

    The circumference of ankle was measured by a tape measure.

    change from baseline after 4 weeks of sock usage

  • Toe Brachial Index

    ratio of systolic blood pressure of toe relative to systolic blood pressure of arm

    change from baseline after 4 weeks of sock usage

  • Ankle Brachial Index

    ratio of systolic blood pressure of ankle relative to systolic blood pressure of arm

    change from baseline after 4 weeks of sock usage

  • Foot Edema

    The circumference of the foot was measured by a tape measure.

    change from baseline after 4 weeks of sock usage

  • Microcirculation for Medial Calf

    microcirculation as measured by skin perfusion pressure

    change from baseline after 4 weeks of sock usage

  • Microcirculation for Lateral Calf

    microcirculation as measured by skin perfusion pressure

    change from baseline after 4 weeks of sock usage

  • Microcirculation for Dorsum of Foot

    microcirculation as measured by skin perfusion pressure

    change from baseline after 4 weeks of sock usage

Secondary Outcomes (1)

  • Physical Activity Level

    baseline and after four weeks of wearing the socks

Study Arms (2)

Mild Compression Diabetic Sock

EXPERIMENTAL

Diabetic socks that provide 18-25mm Hg of pressure to the lower extremities.

Device: mild compression diabetic sock

Standard Diabetic Sock

OTHER

A standard diabetic sock that is designed to limit foot ulcer formation, but does not provide compression to the leg.

Device: Standard diabetic sock

Interventions

A diabetic sock that provides mild compression (18-25mm Hg) is to be worn everyday for four weeks

Mild Compression Diabetic Sock

A diabetic sock that is not designed to provide compression is to be worn everyday for four weeks

Standard Diabetic Sock

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female with lower extremity edema aged 18 or older with the ability and willingness to provide Informed consent
  • Patient's ankle-brachial systolic pressure index \> 0.6 and toe-brachial index \> 0.3
  • Patient is willing to participate in all procedures and follow up evaluations necessary to complete the study.
  • Patient has diabetes type 1 or type 2 confirmed by patient's primary care physician.

You may not qualify if:

  • Patients with active wound infection, or untreated osteomyelitis, gangrene
  • Patients with dementia, or impaired cognitive function that would prohibit study compliance
  • Patients with wide spread malignancy or systemically immuno-compromising disease
  • Patients who are unable or unwilling to participate in all procedures and follow up evaluations
  • Patient with deep and/or large ulcers that require copious bandaging and may affect efficacy of socks. Patients with superficial ulcers that only require a light dressing are not excluded. The ulcer, if present, must be superficial and cannot exhibit any clinical signs of infection
  • Patients with restless leg syndrome, Parkinson's disease, or other disease that will cause involuntary movement during microvascular assessment
  • Patients with severe edema or calf circumference greater than 24" or 46cm
  • Patients with severe lymphedema
  • Patients with edema that in the opinion of the investigator requires higher compression than the 18-25mmHg provided by the compression socks
  • Patients who are currently wearing compression hose. (Patients who have been prescribed compression hose but have not worn compression stockings for the past 6 months can be included in the study)
  • Patients unable to walk one hundred feet.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rosalind Franklin University Health System

North Chicago, Illinois, 60064, United States

Location

MeSH Terms

Conditions

EdemaDiabetes Mellitus

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Results Point of Contact

Title
Ryan Crews, Clinical Scientist
Organization
Center for Lower Extremity Ambulatory Research

Study Officials

  • Stephanie Wu, DPM, MS

    Rosalind Franklin University of Medicine and Science

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Center for Lower Extremity Ambulatory Research

Study Record Dates

First Submitted

February 3, 2012

First Posted

February 8, 2012

Study Start

February 1, 2012

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

June 22, 2016

Results First Posted

June 22, 2016

Record last verified: 2016-05

Data Sharing

IPD Sharing
Will not share

Locations